An-Sofie Verrijssen

Dr. An-Sofie Verrijssen

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2023 in Technical Innovations & Patient Support in Radiation Oncology
Verified
Journal Article
Open access
NBNienke Bakx
Nienke Bakx
DRDorien Rijkaart
Dorien Rijkaart
MSMaurice van der Sangen
Maurice van der Sangen
JTJacqueline Theuws
Jacqueline Theuws
PTPeter-Paul van der Toorn
Peter-Paul van der Toorn
CHCoen Hurkmans
Coen Hurkmans
Deep learning (DL) models are increasingly developed for auto-segmentation in radiotherapy. Qualitative analysis is of great importance for clinical implementation, next to quantitative. This study evaluates a DL segmentation model for left- and right-sided locally advanced breast cancer both quantitatively and qualitatively. For each side a DL model was trained, including primary breast CTV (CTVp), lymph node levels 1–4, heart, lungs, humeral head, thyroid and esophagus. For evaluation, both automatic segmentation, including correction of contours when needed, and manual delineation was performed and both processes were timed. Quantitative scoring with dice-similarity coefficient (DSC), 95% Hausdorff Distance (95%HD) and surface DSC (sDSC) was used to compare both the automatic (not-corrected) and corrected contours with the manual contours. Qualitative scoring was performed by five radiotherapy technologists and five radiation oncologists using a 3-point Likert scale. Time reduction was achieved using auto-segmentation in 95% of the cases, including correction. The time reduction (mean ± std) was 42.4% ± 26.5% and 58.5% ± 19.1% for OARs and CTVs, respectively, corresponding to an absolute mean reduction (hh:mm:ss) of 00:08:51 and 00:25:38. Good quantitative results were achieved before correction, e.g. mean DSC for the right-sided CTVp was 0.92 ± 0.06, whereas correction statistically significantly improved this contour by only 0.02 ± 0.05, respectively. In 92% of the cases, auto-contours were scored as clinically acceptable, with or without corrections. A DL segmentation model was trained and was shown to be a time-efficient way to generate clinically acceptable contours for locally advanced breast cancer.

1 March 2020 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
AVAn-Sofie Verrijssen
An-Sofie Verrijssen
JGJosé Guillem
José Guillem
RPRodrigo Oliva Perez
Rodrigo Oliva Perez
KBKrzysztof Bujko
Krzysztof Bujko
NGNathalie Guedj
Nathalie Guedj
ELEvert J. Van Limbergen
Evert J. Van Limbergen

30 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
VVVincent Cornelis Johannes van de Vlasakker
Vincent Cornelis Johannes van de Vlasakker
THTeun Barend Marijn van den Heuvel
Teun Barend Marijn van den Heuvel
ARAnouk Rijken
Anouk Rijken
SNSimon W. Nienhuijs
Simon W. Nienhuijs
SKStijn Ketelaers
Stijn Ketelaers
IHIgnace de Hingh
Ignace de Hingh
Purpose: To assess the safety and long-term outcome of a multimodality treatment consisting of radical surgery, intra-operative radiotherapy (IORT), and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for patients with locally advanced rectal cancer (LARC) or locally recurrent rectal carcinoma (LRRC) and peritoneal metastases (PM). Methods: The present study was a single-center cohort study, including all consecutive patients undergoing this treatment in a tertiary referral center for LARC, LRRC, and PM. Postoperative complications, intensive care stay (ICU stay), and re-admission rates were assessed as well as disease-free survival (DFS) and overall survival (OS). Results: A total of 14 LARC and 16 LRRC patients with PM were included in the study. The median ICU stay was 1 day, and 57% of patients developed a severe postoperative complication. No 90-day mortality was observed. Median DFS was 10.0 months (Interquartile Range 7.1–38.7), and median OS was 31.0 months (Interquartile Range 15.9–144.3). Conclusions: As postoperative complications and survival were in line with treatments that are accepted for LARC or LRRC and PM as separate procedures, we conclude that combined treatment with IORT and CRS-HIPEC should be considered as a treatment option for selected patients with LARC or LRRC and peritoneal metastases in tertiary referral centers.

20 January 2024 in Clinical Oncology
Verified
Journal Article
Closed access
AVAn-Sofie Verrijssen
An-Sofie Verrijssen
JEJ. Evers
J. Evers
MSM. van der Sangen
M. van der Sangen
SSS. Siesling
S. Siesling
MAM.J. Aarts
M.J. Aarts
MBM. Berbee
M. Berbee

15 October 2022 in Clinical Oncology
Verified
Journal Article
Closed access
AVAn-Sofie Verrijssen
An-Sofie Verrijssen
SKS.H.J. Ketelaers
S.H.J. Ketelaers
HRH.J.T. Rutten
H.J.T. Rutten
JTJ. Theuws
J. Theuws
JBJ.W.A. Burger
J.W.A. Burger
JCJ.S. Cnossen
J.S. Cnossen

11 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SKStijn Ketelaers
Stijn Ketelaers
AJAnne Jacobs
Anne Jacobs
AVAn-Sofie Verrijssen
An-Sofie Verrijssen
JCJeltsje S. Cnossen
Jeltsje S. Cnossen
IHIrene E. G. van Hellemond
Irene E. G. van Hellemond
JBJacobus W. A. Burger
Jacobus W. A. Burger
Despite it being the optimal curative approach, elderly and frail rectal cancer patients may not be able to undergo a total mesorectal excision. Frequently, no treatment is offered at all and the natural course of the disease is allowed to unfold. These patients are at risk for developing debilitating symptoms that impair quality of life and require palliative treatment. Recent advancements in non-operative treatment modalities have enhanced the toolbox of alternative treatment strategies in patients unable to undergo surgery. Therefore, a proposed strategy is to aim for the maximal non-operative treatment, in an effort to avoid the onset of debilitating symptoms, improve quality of life, and prolong survival. The complexity of treating elderly and frail patients requires a patient-centred approach to personalise treatment. The main challenge is to optimise the balance between local control of disease, patient preferences, and the burden of treatment. A comprehensive geriatric assessment is a crucial element within the multidisciplinary dialogue. Since limited knowledge is available on the optimal non-operative treatment strategy, these patients should be treated by dedicated multidisciplinary rectal cancer experts with special interest in the elderly and frail. The aim of this narrative review was to discuss a multidisciplinary patient-centred treatment approach and provide a practical suggestion of a successfully implemented clinical care pathway.